When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMA - ADMA Bio wins South Korean approval for sale of source plasma
ADMA Biologics Inc
ADMA Biologics' (ADMA) plasma collection center in Kennesaw, Georgia has received approval from the Korean Ministry of Food and Drug Safety ((MFDS)) for the sale of source plasma into South Korea.In addition, ADMA announced the Kennesaw plasma collection center received FDA approval to implement a Hepatitis B immunization program, enabling the company to collect source plasma from donors immunized with an FDA-licensed Hepatitis B vaccine.ADMA shares up 2.5% premarket trading at $2.44.